Surgical resection of malignant gliomas—role in optimizing patient outcome

@article{Eypoglu2013SurgicalRO,
  title={Surgical resection of malignant gliomas—role in optimizing patient outcome},
  author={Ilker Y. Ey{\"u}poglu and Michael Buchfelder and Nic E. Savaskan},
  journal={Nature Reviews Neurology},
  year={2013},
  volume={9},
  pages={141-151}
}
Malignant gliomas represent one of the most devastating human diseases. Primary treatment of these tumours involves surgery to achieve tumour debulking, followed by a multimodal regimen of radiotherapy and chemotherapy. Survival time in patients with malignant glioma has modestly increased in recent years owing to advances in surgical and intraoperative imaging techniques, as well as the systematic implementation of randomized trial-based protocols and biomarker-based stratification of patients… Expand
Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center
TLDR
The data show a higher frequency of complete resection in patients with GBM after the establishment of a series of technical developments that resulted in significantly better PFS and OS without increasing surgery-related morbidity. Expand
Current approaches to the treatment of metastatic brain tumours
TLDR
This Review focuses on the clinically relevant molecular biology of brain metastases, and summarizes the current applications of these data to imaging, surgery, radiation therapy, cytotoxic chemotherapy and targeted therapy. Expand
Principles of surgery for malignant astrocytomas.
Malignant astrocytomas constitute the most aggressive and common primary tumors of the central nervous system. The standard treatment protocol for these tumors involves maximum safe surgicalExpand
Fluorescence-Guided versus Conventional Surgical Resection of High Grade Glioma: A Single-Centre, 7-Year, Comparative Effectiveness Study.
TLDR
This study showed a significant clinical benefit for HGG patients in terms of overall survival using fluorescence-guided surgery as it did not result in worsening of post-operative function outcome when compared with the conventional surgical method. Expand
A new functional classification system (FGA/B) with prognostic value for glioma patients
TLDR
A novel classification system of preoperative tumor status, which considers tumor operability based on two graduations (Friedlein Grading - FG), which provides high prognostic value with respect to overall survival time in relation to the extent of location-dependent tumor resection. Expand
Patient-Specific Metrics of Invasiveness Reveal Significant Prognostic Benefit of Resection in a Predictable Subset of Gliomas
TLDR
Results suggest that patient-specific, model-based estimates of tumor invasiveness have clinical utility in surgical decision making and Quantification of relativeInvasiveness assessed from routinely obtained pre-operative imaging provides a practical predictor of the benefit of gross total resection. Expand
Aggressive Treatment in Glioblastoma: What Determines the Survival of Patients?
TLDR
No distinct markers consistently have been identified in long-term survivors of GBM patients, and great importance should be attached to further understand the biological characteristics of the invasive glioma cells because of the nature of diffuse tumor permeation. Expand
Analysis of the Factors Affecting the Prognosis of Glioma Patients
TLDR
The prognosis of glioma patients treated in this retrospective study was negatively affected by age, tumor grade, KPS, and partial tumor resection, and surgical resection combined with chemotherapy and multi-course use of TMZ prolongs the survival time of patients. Expand
Resection and survival data from a clinical trial of glioblastoma multiforme‐specific IRDye800‐BBN fluorescence‐guided surgery
TLDR
GBM‐specific fluorescent IRDye800‐BBN can help neurosurgeons identify the tumor boundary with sensitivity and specificity, and may improve survival outcomes. Expand
Pericytes in Glioblastomas: Multifaceted Role Within Tumor Microenvironments and Potential for Therapeutic Interventions.
TLDR
Hallmarks of GBM are introduced and the contributions of pericytes to these hallmarks are elaborated on by examining recent findings, while discussing conventional and novel GBM therapies and obstacles to their efficacy. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 146 REFERENCES
An extent of resection threshold for newly diagnosed glioblastomas.
TLDR
For patients with newly diagnosed GBMs, aggressive EOR equates to improvement in overall survival, even at the highest levels of resection, and stepwise improvement in survival was evident even in the 95%-100% EOR range. Expand
Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma
TLDR
There is definite hope that by 2020, new cocktails of drugs will be available to target the key molecular pathways involved in gliomas and reduce their mortality and morbidity, a positive development for patients, their families, and medical professionals alike. Expand
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.
TLDR
These data provide Class II evidence to support tumor grade, patient's age, and patient's functional status as prognostic factors for survival in individuals with recently diagnosed malignant gliomas. Expand
Usefulness of intraoperative magnetic resonance imaging for glioma surgery.
TLDR
Use of iMRI during surgery for intracranial gliomas permits to attain aggressive tumour resection with good functional outcome, and surgical experience with the iMRI system, establishment of treatment algorithm, and improvement of image quality are of paramount importance for optimal results. Expand
Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
TLDR
In the authors' experience with both primary and secondary resection of malignant brain astrocytomas, increasing extent of resection was associated with improved survival independent of age, degree of disability, WHO grade, or subsequent treatment modalities used. Expand
Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival
TLDR
It is shown that elderly GBM patients can benefit from maximum treatment procedures with cytoreductive microsurgery, radiation therapy, and chemotherapy, and should not be per se excluded from intensive treatment procedures. Expand
Influence of iMRI-Guidance on the Extent of Resection and Survival of Patients with Glioblastoma Multiforme
TLDR
Intraoperative MRI is a helpful tool to increase the extent of resection in GBM surgery and thereby improve patient survival and the rate of complete tumor resections was significantly higher in the iMRI group than in the conventional surgery group. Expand
Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome.
TLDR
A critical review of literature pertinent to low-grade gliomas of the cerebral hemisphere in adults was performed to evaluate systematically the prognostic effect of extent of resection on survival and to determine if treatment-related guidelines could be established for patients in whom these tumors have been newly diagnosed. Expand
Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.
TLDR
It is concluded that biopsy only yields inferior survival to more extensive surgery for patients with glioblastoma multiforme treated with surgery and radiation therapy. Expand
High-field iMRI in glioblastoma surgery: improvement of resection radicality and survival for the patient?
Since the first patients underwent intracranial tumor removal with the radicality control of intraoperative MRI (ioMRI) in September 2005 in our department, the majority of operations performed inExpand
...
1
2
3
4
5
...